GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovaQor Inc (OTCPK:INQR) » Definitions » EV-to-EBIT

InnovaQor (InnovaQor) EV-to-EBIT : -1.22 (As of May. 27, 2024)


View and export this data going back to . Start your Free Trial

What is InnovaQor EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, InnovaQor's Enterprise Value is $2.14 Mil. InnovaQor's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.75 Mil. Therefore, InnovaQor's EV-to-EBIT for today is -1.22.

The historical rank and industry rank for InnovaQor's EV-to-EBIT or its related term are showing as below:

INQR' s EV-to-EBIT Range Over the Past 10 Years
Min: -2.19   Med: -1.22   Max: -0.37
Current: -1.22

During the past 8 years, the highest EV-to-EBIT of InnovaQor was -0.37. The lowest was -2.19. And the median was -1.22.

INQR's EV-to-EBIT is ranked worse than
100% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 17.65 vs INQR: -1.22

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. InnovaQor's Enterprise Value for the quarter that ended in Sep. 2023 was $3.19 Mil. InnovaQor's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.75 Mil. InnovaQor's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -54.96%.


InnovaQor EV-to-EBIT Historical Data

The historical data trend for InnovaQor's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovaQor EV-to-EBIT Chart

InnovaQor Annual Data
Trend Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Dec21 Dec22
EV-to-EBIT
Get a 7-Day Free Trial -62.07 -15.94 -3.28 -1.36 -2.20

InnovaQor Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.46 -2.20 -1.98 -1.79 -1.82

Competitive Comparison of InnovaQor's EV-to-EBIT

For the Health Information Services subindustry, InnovaQor's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovaQor's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovaQor's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where InnovaQor's EV-to-EBIT falls into.



InnovaQor EV-to-EBIT Calculation

InnovaQor's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.137/-1.753
=-1.22

InnovaQor's current Enterprise Value is $2.14 Mil.
InnovaQor's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnovaQor  (OTCPK:INQR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

InnovaQor's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-1.753/3.189718
=-54.96 %

InnovaQor's Enterprise Value for the quarter that ended in Sep. 2023 was $3.19 Mil.
InnovaQor's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InnovaQor EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of InnovaQor's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


InnovaQor (InnovaQor) Business Description

Traded in Other Exchanges
N/A
Address
400 S. Australian Avenue, Suite 800, West Palm Beach, FL, USA, 33401
InnovaQor Inc provides information technology solutions and services to healthcare and laboratory customers in the United States. Its goal is to develop and deliver a technology-based medical professional's network communication platform to a broad range of healthcare professionals and businesses using a subscription revenue model with added value bolt-on services.
Executives
Francisco Iii Roca director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Darrell L Peterson director, officer: Chief Executive Officer 2390 CIRCLE DRIVE, WEST PALM BEACH FL 33406
Sharon Lynne Hollis director 400 SOUTH AUSTRALIAN AVENUE, 8TH FLOOR, WEST PALM BEACH FL 33401
Justin Doherty director 400 S. AUSTRALIAN AVENUE, SUITE 800, WEST PALM BEACH FL 33401
Thomas Joseph Bellante officer: Chief Financial Officer 14706 CROYDON PLACE, TAMPA FL 33618
Jayne Kirby officer: VP Finance 1035 LAURIER O., SUITE 200, MONTREAL A8 H2V 2L1
Arthur Gelston 10 percent owner 1035 LAURIER STREET WEST, MONTREAL A8 H2V 2L1
Visual Healthcare Corp 10 percent owner 790 ROCKLAND AVE., MONTREAL, QC. A8 H2V 2Z6
Philippe Rainville officer: CFO 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Philippe Panzini director 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Michel Maksud officer: VP Technology 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Gerard Dab director, officer: CEO and Chairman of the Board 391A LAURIER WEST, MONTREAL A8 H2V 2K3
Louis J Lombardo director 108 SMITH LAKE ROAD, ROSCOE NY 12776
Visualmed Clinical Systems Corp 10 percent owner
Barry Scharf officer: VP Operations 391A LAURIER WEST, MONTREAL A8 H2V 2K3